An Open Label Clinical Non-Randomized Study to Evaluate the Efficacy of Patola-Nimbadi Basti in the Management of Psoriasis w.s.r. to Ekakushtha - NI

Institute for Ayurved Studies and Research Umri Road Kurukshetra Haryana0 sites0 target enrollmentStarted: TBDLast updated: July 22, 2024

Trial Snapshot

No summary available.

•1. Subjects presenting with clinical features of Psoriasis.
•2. Patients suffering from psoriasis with less than 50% of the body surface involvement.
•3. Subjects with chronicity of disease more than 6 months and less than 5 yrs.
•4. The patient who is fit for Basti Karma (Basti Yogya).

•1. Patient presenting with clinical features other than psoriasis like generalized skin
•lesions, herpes simplex, herpes zooster, scabies, acne, urticaria and immunological
•medicated skin diseases like pemphigus vulgaris, dermatitis herpetiformis, guttate
•psoriasis, pustular psoriasis, lupus erythematous, psoriatic arthropathy etc.
•2. Patient suffering from severe psoriasis with more than 50% of the body surface
•involvement.
•3. Patient with chronicity of disease less than 6 months and above 5 yrs.
•4. Subjects of either sex age below 20 years and above 60 years.
•5. Patient on medication like corticosteroids, phototherapy, biologics, antidepressant
•and any other drugs that may have an influence on the outcome of the study .
•6. Alcoholics or drug abusers.
•7. Systemic Lupus Erythematous and other Auto Immune disorders.
•8. Patients having systematic pathologies like cardiac diseases, renal diseases and
•endocrine disorders.
•9. Pregnant and lactating women.
•10. Patient who are contra-indicated for Basti Karma (Basti Ayogya).

Sponsor

Institute for Ayurved Studies and Research Umri Road Kurukshetra Haryana